Vertiv, (NYSE: VRT) (www.Vertiv.com/en-emea), a global provider of critical digital infrastructure and continuity solutions, today announced additions and enhancements to the Vertiv Partner Program (https://bit.ly/30okRmr) to expand access to IT decision makers and enrich the Vertiv experience for partners and customers. The investment in the Partner Program includes new global channel oversight and a new […]
Anavex Life Sciences Reports Fiscal 2020 Year End Financial Results And Clinical Program Updates marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Anavex Life Sciences Reports Fiscal 2020 Year End Financial Results And Clinical Program Updates
Anavex Life Sciences Corp.December 28, 2020 GMT
NEW YORK, Dec. 28, 2020 (GLOBE NEWSWIRE) Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today reported financial results for its fiscal year ended September 30, 2020.
Christopher U Missling, PhD, President and Chief Executive Officer of Anavex said: “Despite all of the new challenges, 2020 was an extraordinary year for Anavex, with significant progress across our portfolio, including our first positive, placebo-controlled, U.S. ANAVEX®2-7